ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze - 
68178001 Takeda Pharma AG
TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze05.11.2020
  05.11.2020
Lanadelumab (B06AC05) 
WHO-DDD 
02.99. 
02.99. 
B  
Yes 
IPCI
9412.34Yes
    
10 %9964.85
7680681780014Biotechnologika
  
Composition
lanadelumabum 300 mg, dinatrii phosphas dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 6.91 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Lanadelumabum300mg / 2ml
BAG: Active AgentDose
Lanadelumabum300 mg
 
Inactive agents
Citric Acid Monohydrate
Disodium Phosphate Dihydrate
Histidine
Sodium Chloride
Polysorbatum 80
 
Source
Data was imported : 04.04.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home